Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia

Ciftciler, Rafiye; DEMİROĞLU, HALUK; BÜYÜKAŞIK, YAHYA; AKSU, SALİH; Gokei, Hakan

doi:10.1016/j.clml.2018.12.006

Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia

Atıf İçin Kopyala

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., Gokei H.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.19, sa.5, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Sayı: 5
Basım Tarihi: 2019
Doi Numarası: 10.1016/j.clml.2018.12.006
Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Hacettepe Üniversitesi Adresli: Evet

Özet

The aim of this study to impact of blood count recovery based complete remission before allogeneic hematopoietic stem cell transplantation (alloHSCT) on survival in patients with acute myeloid leukemia. We observed an equivalent post-transplant outcome between patients who were in complete remission and patients who were in complete response with incomplete blood count recovery before alloHSCT. We assume that alloHSCT eliminated the negative effect of pretransplant blood count levels.